US Tariffs on Pharmaceutical Products from Kuwait — 10% (2026)
Tariff Rate Breakdown
The United States imports substantial quantities of pharmaceutical products from Kuwait, with approximately $8B in total bilateral trade.
Following the Supreme Court's landmark February 20, 2026 decision striking down IEEPA tariffs, imports of pharmaceutical products from Kuwait are now subject to a 10% tariff under Section 122 of the Trade Act of 1974, effective February 24, 2026.
This 10% rate has a built-in expiration: Section 122 limits presidential tariff authority to 150 days, meaning the tariff expires approximately July 24, 2026 without congressional renewal.
Pharmaceutical Products (HTS Chapter 30) generally enter duty-free at the MFN level, with the Section 122 tariff as the primary duty. No additional Section 232 or Section 301 surcharges apply to most products in this category from Kuwait.
Key products in HTS Chapter 30 imported from Kuwait include Vaccines, Antibiotics, Insulin, Bandages, Diagnostic reagents, and Blood products.
Common Products in Chapter 30
Calculate Your Import Duty
Use our tariff calculator to estimate the exact duty on your pharmaceutical products imports from Kuwait.
Open Tariff CalculatorFrequently Asked Questions
What is the current tariff rate on pharmaceutical products from Kuwait?
Will the tariff on pharmaceutical products from Kuwait change?
How did the Supreme Court ruling affect pharmaceutical products imports from Kuwait?
Pharmaceutical Products Tariffs from Other Countries
Other Product Categories from Kuwait
Specific HTS Codes in Chapter 30
Related Pages
Tariff rates change fast. Stay ahead.
Free alerts when US import tariff rates change. Join importers and trade professionals who stay informed.
No spam. Unsubscribe anytime.